Leverus, thanks for joining in and welcome to the forum.

The momentum is building. It has been 21 years of scientific success and very little success on the business side of RVX. 

If you have family, friends or acquaintances that hold RVX and may have forgotton about their RVX holdings please urge them to express their power as shareholders. Every vote counts.

Let's get the "withhold" well beyond 10% and show our dissatisfaction with the abuse of forward looking statements and mushroom management.

Thanks to DebkCardsPA for the link on the recent scientific discoveries on apabetalone. The scientific team continues to excell in spite of management incompetence. IMHO Dr Kulokoski's salary should be moved form $250,000 to $500,000 and Don's should be cut to $250,000 or less.

Please get out and vote "withold" for each board member. It is the one way we can influence the much needed change. This BOD or a new one must start doing their jobs as directors and be accountable to all shareholders.

GLTA

Toinv